penicillamine has been researched along with Ptosis, Eyelid in 6 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 68-year-old black woman who was put on D-penicillamine therapy (250-500 mg per day, total dose 15 g) for rheumatoid arthritis developed ocular myasthenia gravis." | 8.77 | Ocular myasthenia gravis after D-penicillamine administration. ( Katz, LJ; Lesser, RL; Merikangas, JR; Silverman, JP, 1989) |
| " Both patients (one case of progressive systemic sclerosis and one of rheumatoid arthritis) were currently taking D-penicillamine." | 7.68 | Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis. ( Fries, JF; Kornfeld, P; Lee, YS; Raynauld, JP, 1993) |
| "A 68-year-old black woman who was put on D-penicillamine therapy (250-500 mg per day, total dose 15 g) for rheumatoid arthritis developed ocular myasthenia gravis." | 4.77 | Ocular myasthenia gravis after D-penicillamine administration. ( Katz, LJ; Lesser, RL; Merikangas, JR; Silverman, JP, 1989) |
| " Both patients (one case of progressive systemic sclerosis and one of rheumatoid arthritis) were currently taking D-penicillamine." | 3.68 | Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis. ( Fries, JF; Kornfeld, P; Lee, YS; Raynauld, JP, 1993) |
| "D-penicillamine is a potent drug used to treat rheumatoid arthritis, Wilson's disease and cystinuria." | 3.66 | D-penicillamine and the ocular myasthenic syndrome. ( Kimbrough, RL; Mewis, L; Stewart, RH, 1981) |
| "A 59-year-old woman has been treated for 5 months with penicillamine for a rheumatoid arthritis and developed a myasthenia syndrome with ptosis, diplopia, dysphagia and asthenia." | 3.66 | [Myasthenia syndrome after peroral treatment with penicillamine]. ( Francois, J; Gabriel, P; Verbraeken, H; Wille, C, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimbrough, RL | 1 |
| Mewis, L | 1 |
| Stewart, RH | 1 |
| Raynauld, JP | 1 |
| Lee, YS | 1 |
| Kornfeld, P | 1 |
| Fries, JF | 1 |
| Atcheson, SG | 1 |
| Ward, JR | 1 |
| Francois, J | 2 |
| Verbraeken, H | 2 |
| Gabriel, P | 2 |
| Wille, C | 2 |
| Katz, LJ | 1 |
| Lesser, RL | 1 |
| Merikangas, JR | 1 |
| Silverman, JP | 1 |
1 review available for penicillamine and Ptosis, Eyelid
| Article | Year |
|---|---|
Ocular myasthenia gravis after D-penicillamine administration.
Topics: Aged; Blepharoptosis; Diplopia; Female; Humans; Myasthenia Gravis; Penicillamine | 1989 |
5 other studies available for penicillamine and Ptosis, Eyelid
| Article | Year |
|---|---|
D-penicillamine and the ocular myasthenic syndrome.
Topics: Arthritis, Rheumatoid; Blepharoptosis; Diplopia; Female; Humans; Middle Aged; Myasthenia Gravis; Pen | 1981 |
Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
Topics: Adult; Arthritis, Rheumatoid; Blepharoptosis; Female; Humans; Myasthenia Gravis; Penicillamine; Scle | 1993 |
Ptosis and weakness after start of D-penicillamine therapy.
Topics: Blepharoptosis; Humans; Male; Middle Aged; Muscular Diseases; Penicillamine; Time Factors | 1978 |
[Myasthenia syndrome after peroral treatment with penicillamine].
Topics: Arthritis, Rheumatoid; Blepharoptosis; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1978 |
[Myasthenic syndrome following oral treatment with penicillamine].
Topics: Arthritis, Rheumatoid; Blepharoptosis; Deglutition Disorders; Diplopia; Female; Humans; Middle Aged; | 1978 |